| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$101,857,598 |
|
|
|
Indirect Value
|
$7,230,549 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$109,088,147 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
159 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-05-04 |
4 |
OE |
$27.07 |
$2,165,600 |
D/D |
80,000 |
1,294,306 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2014-03-06 |
4 |
D |
$79.92 |
$6,630,803 |
D/D |
(82,968) |
938,048 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-07 |
4 |
S |
$44.45 |
$3,880,546 |
D/D |
(87,300) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-07 |
4 |
OE |
$8.94 |
$780,680 |
D/D |
87,300 |
337,175 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2014-05-08 |
4 |
OE |
$8.01 |
$800,500 |
D/D |
100,000 |
1,038,048 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-05-07 |
4 |
AS |
$100.39 |
$10,100,162 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-05-07 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-06-08 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-06-08 |
4 |
AS |
$114.03 |
$11,405,413 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-07-07 |
4 |
AS |
$113.65 |
$11,444,077 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-07-07 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-08-07 |
4 |
AS |
$113.73 |
$11,393,948 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-08-07 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-09-08 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-09-08 |
4 |
AS |
$103.39 |
$10,338,730 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-10-07 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-10-07 |
4 |
AS |
$98.04 |
$9,921,524 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-11-09 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-11-09 |
4 |
AS |
$107.60 |
$10,765,644 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-12-07 |
4 |
OE |
$14.50 |
$1,450,250 |
D/D |
100,000 |
1,129,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2015-12-07 |
4 |
AS |
$102.93 |
$10,317,977 |
D/D |
(100,000) |
1,029,108 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-23 |
4 |
OE |
$21.58 |
$2,157,500 |
D/D |
100,000 |
1,165,924 |
0 |
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2020-12-15 |
4 |
B |
$23.00 |
$2,300,000 |
I/I |
100,000 |
100,000 |
2.1 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-06 |
4 |
S |
$44.09 |
$4,508,043 |
D/D |
(102,248) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-06 |
4 |
OE |
$8.94 |
$914,353 |
D/D |
102,248 |
352,123 |
0 |
- |
|
159 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
